Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Current Assets (2021 - 2025)

Lucid Diagnostics' Current Assets history spans 5 years, with the latest figure at $37.5 million for Q4 2025.

  • For Q4 2025, Current Assets rose 48.99% year-over-year to $37.5 million; the TTM value through Dec 2025 reached $37.5 million, up 48.99%, while the annual FY2025 figure was $37.5 million, 48.99% up from the prior year.
  • Current Assets reached $37.5 million in Q4 2025 per LUCD's latest filing, down from $49.8 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $57.3 million in Q4 2021 to a low of $2.5 million in Q3 2021.
  • Average Current Assets over 5 years is $32.0 million, with a median of $28.9 million recorded in 2022.
  • The largest YoY upside for Current Assets was 1091.73% in 2022 against a maximum downside of 57.5% in 2022.
  • A 5-year view of Current Assets shows it stood at $57.3 million in 2021, then plummeted by 57.5% to $24.4 million in 2022, then dropped by 9.37% to $22.1 million in 2023, then grew by 13.93% to $25.1 million in 2024, then skyrocketed by 48.99% to $37.5 million in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Current Assets are $37.5 million (Q4 2025), $49.8 million (Q3 2025), and $33.8 million (Q2 2025).